These results clearly indicate that the suppression of CCl4-induced hepatic fibrosis in the vaccinated mice is attributable to the blockage of TGF-β1 signaling and further attenuation of the activation of HSCs. The gene discussed is TGFB1; the disease is Hepatic fibrosis.